Indaptus Therapeutics, Inc. Common Stock INDP
$3.21
+10.69%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2024-11-13 | Maxim GroupJason McCarthy |
Maintains | Buy | $8 → $5 |
| 2024-10-16 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2024-06-17 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2024-04-15 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-09-20 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-08-15 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-08-11 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-08-08 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-05-04 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $12 |
| 2023-03-20 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $15 → $12 |
| 2023-03-08 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Overweight | $15 |
| 2023-02-08 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $15 |
| 2022-01-31 | HC Wainwright & Co.Raghuram Selvaraju |
Assumes | Buy | $15 |
| 2021-10-19 | Maxim GroupJason McCarthy |
Upgrades | Hold → Buy | $16 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.21
- Market Cap
- $427.71 million
- 52-Week Range
- $0.92 – $5.96
- Average Volume
- 352K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.